Dexdor (dexmedetomidine)
- Region
- 🇪🇺 EU
- Active substance
- dexmedetomidine
- Company
- Orion Corporation
- Status
- Authorised
- Therapeutic area
- Conscious Sedation
- EU approval
- Thu 15 Sep 2011
- Application
- EMEA/H/C/002268
- ATC
- N05CM18
- Official record
- www.ema.europa.eu
Indication
For sedation of adult intensive care unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to Richmond Agitation-Sedation Scale (RASS) 0 to -3).
Regulatory milestones
No milestones recorded in the last year.
Follow Dexdor
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.